Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postmenopause

Age range

40 year–65 year

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients in whom Premarin vaginal cream is indicated.
In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study.
Provide signed informed consent.

Exclusion criteria

Patients not willing to give informed consent.

Treatment and study plan

Conjugated Estrogen Cream (Premarin®)

Drug

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women

Important dates

Study start: 2005
Study completion: 2006
First posted: Jun 8, 2007
Registry last updated: Dec 28, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed